Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Incyte Corporation (INCY)

-NasdaqGS
85.85 Down 1.69(1.93%) Feb 27, 4:00PM EST
|After Hours : 85.85 0.00 (0.00%) Feb 27, 4:25PM EST
Add to Portfolio
Prev Close:87.54
Open:87.01
Bid:N/A
Ask:108.30 x 100
1y Target Est:91.08
Beta:0.02
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:84.23 - 87.60
52wk Range:40.30 - 88.44
Volume:917,065
Avg Vol (3m):1,157,150
Market Cap:14.75B
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 1.93%14.75B
AMGNDown 0.79%119.69B
CELGDown 1.48%97.30B
RHHBYUp 0.80%N/A

Key Statistics

Forward P/E (1 yr):85.00
P/S (ttm):29.40
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.25
Quarterly EPS Est (Mar-15) :-0.08
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-4.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback